» Articles » PMID: 31308097

RGS4 Maintains Chronic Pain Symptoms in Rodent Models

Abstract

Regulator of G-protein signaling 4 (RGS4) is a potent modulator of G-protein-coupled receptor signal transduction that is expressed throughout the pain matrix. Here, we use genetic mouse models to demonstrate a role of RGS4 in the maintenance of chronic pain states in male and female mice. Using paradigms of peripheral inflammation and nerve injury, we show that the prevention of RGS4 action leads to recovery from mechanical and cold allodynia and increases the motivation for wheel running. Similarly, RGS4KO eliminates the duration of nocifensive behavior in the second phase of the formalin assay. Using the Complete Freud's Adjuvant (CFA) model of hindpaw inflammation we also demonstrate that downregulation of RGS4 in the adult ventral posterolateral thalamic nuclei promotes recovery from mechanical and cold allodynia. RNA sequencing analysis of thalamus (THL) from RGS4WT and RGS4KO mice points to many signal transduction modulators and transcription factors that are uniquely regulated in CFA-treated RGS4WT cohorts. Ingenuity pathway analysis suggests that several components of glutamatergic signaling are differentially affected by CFA treatment between RGS4WT and RGS4KO groups. Notably, Western blot analysis shows increased expression of metabotropic glutamate receptor 2 in THL synaptosomes of RGS4KO mice at time points at which they recover from mechanical allodynia. Overall, our study provides information on a novel intracellular pathway that contributes to the maintenance of chronic pain states and points to RGS4 as a potential therapeutic target. There is an imminent need for safe and efficient chronic pain medications. Regulator of G-protein signaling 4 (RGS4) is a multifunctional signal transduction protein, widely expressed in the pain matrix. Here, we demonstrate that RGS4 plays a prominent role in the maintenance of chronic pain symptoms in male and female mice. Using genetically modified mice, we show a dynamic role of RGS4 in recovery from symptoms of sensory hypersensitivity deriving from hindpaw inflammation or hindlimb nerve injury. We also demonstrate an important role of RGS4 actions in gene expression patterns induced by chronic pain states in the mouse thalamus. Our findings provide novel insight into mechanisms associated with the maintenance of chronic pain states and demonstrate that interventions in RGS4 activity promote recovery from sensory hypersensitivity symptoms.

Citing Articles

Reduced striatal M4-cholinergic signaling following dopamine loss contributes to parkinsonian and l-DOPA-induced dyskinetic behaviors.

Nielsen B, Ford C Sci Adv. 2024; 10(47):eadp6301.

PMID: 39565858 PMC: 11578179. DOI: 10.1126/sciadv.adp6301.


Cytokines reprogram airway sensory neurons in asthma.

Crosson T, Bhat S, Wang J, Salaun C, Fontaine E, Roversi K bioRxiv. 2024; .

PMID: 39345572 PMC: 11429693. DOI: 10.1101/2023.01.26.525731.


Role of HDAC5 Epigenetics in Chronic Craniofacial Neuropathic Pain.

Hui S, Westlund K Int J Mol Sci. 2024; 25(13).

PMID: 38999998 PMC: 11241576. DOI: 10.3390/ijms25136889.


Desipramine induces anti-inflammatory dorsal root ganglion transcriptional signatures in the murine spared nerve injury model.

Serafini R, Ramakrishnan A, Shen L, Zachariou V Neurobiol Pain. 2024; 15:100153.

PMID: 38549875 PMC: 10973649. DOI: 10.1016/j.ynpai.2024.100153.


Neuron-astrocyte metabolic coupling facilitates spinal plasticity and maintenance of inflammatory pain.

Marty-Lombardi S, Lu S, Ambroziak W, Schrenk-Siemens K, Wang J, DePaoli-Roach A Nat Metab. 2024; 6(3):494-513.

PMID: 38443593 PMC: 10963271. DOI: 10.1038/s42255-024-01001-2.


References
1.
Lerner T, Kreitzer A . RGS4 is required for dopaminergic control of striatal LTD and susceptibility to parkinsonian motor deficits. Neuron. 2012; 73(2):347-59. PMC: 3269032. DOI: 10.1016/j.neuron.2011.11.015. View

2.
Anders S, Pyl P, Huber W . HTSeq--a Python framework to work with high-throughput sequencing data. Bioinformatics. 2014; 31(2):166-9. PMC: 4287950. DOI: 10.1093/bioinformatics/btu638. View

3.
Roeckel L, Utard V, Reiss D, Mouheiche J, Maurin H, Robe A . Morphine-induced hyperalgesia involves mu opioid receptors and the metabolite morphine-3-glucuronide. Sci Rep. 2017; 7(1):10406. PMC: 5583172. DOI: 10.1038/s41598-017-11120-4. View

4.
Miyata M, Kashiwadani H, Fukaya M, Hayashi T, Wu D, Suzuki T . Role of thalamic phospholipase C[beta]4 mediated by metabotropic glutamate receptor type 1 in inflammatory pain. J Neurosci. 2003; 23(22):8098-108. PMC: 6740489. View

5.
Wang J, Zhang H, Han J, Chang J, Woodward D, Luo F . Differential modulation of nociceptive neural responses in medial and lateral pain pathways by peripheral electrical stimulation: a multichannel recording study. Brain Res. 2004; 1014(1-2):197-208. DOI: 10.1016/j.brainres.2004.04.029. View